Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

BACKGROUND: Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T2D), cardiovascular disease (CVD) and mortality....

Descripción completa

Detalles Bibliográficos
Autores principales: Boersma, Henderikus E., van Waateringe, Robert P., van der Klauw, Melanie M., Graaff, Reindert, Paterson, Andrew D., Smit, Andries J., Wolffenbuttel, Bruce H. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802158/
https://www.ncbi.nlm.nih.gov/pubmed/33435948
http://dx.doi.org/10.1186/s12902-020-00676-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802158/
https://www.ncbi.nlm.nih.gov/pubmed/33435948
http://dx.doi.org/10.1186/s12902-020-00676-4

Ejemplares similares